|
 |
Participation in Events
S*BIO participates in various international events and scientific conferences.
Date
|
Event
|
| December 2011 |
2011 ASH Annual Meeting and Exposition |
|
Dr. Rami S. Komrokji (Moffitt Cancer Center) will be making an oral presentation entitled “Results of a Phase 2 Study of Pacritinib (SB1518), a Novel Oral JAK2 Inhibitor, In Patients with Primary, Post-Polycythemia Vera, and Post Essential Thrombocythemia” at the upcoming ASH meeting in San Diego.
At the same event, Dr Alfonso Quintas-Cardama, a principal investigator from The University of Texas M.D. Anderson Cancer Center, will be presenting a poster “Therapy with the Histone Deacetylase Inhibitor SB939 for Patients with Myelofibrosis”.
Session:
Venue:
Room:
Session:
Venue:
Room:
|
12 Dec 2011, 8:15 AM
San Diego Convention Center
6B (Myeloproliferative Syndromes: Clinical Advances I)
12 Dec 2011, 6:00 PM -8:00 PM
San Diego Convention Center
Hall GH (Myeloproliferative Syndromes: Poster III)
|
|
| June 2011 |
11th International Conference on Malignant Lymphoma |
|
Dr Anas Younes from the University of Texas will be presenting at the 11th International Conference on Maliglant Lymphoma being held in Lugano, Switzerland. His presentation entitled “Phase 1 Study of a Novel Oral JAK2 Inhibitor, SB1518, in Patients with Relapsed Lymphoma: Evidence of Clinical and Biologic Activity in Multiple Lymphoma Subtypes” will take place on the 18th June 2011.
Session:
Venue:
Room:
|
18th June 2011, 10.45am
Lugano Convention Centre, Lugano, Switzerland
Session 14, Room A
|
|
| June 2011 |
EHA 16th Congress |
|
Dr John Seymour, Head of the Department of Haematology at the Peter MacCallum Cancer Centre, Melbourne will present a poster entitled, “Long-Term Safety and Efficacy Analysis of the Two Phase 1 Studies of SB1518, a Novel Oral JAK2 Inhibitor, in Patents With Advanced Myeloid Malignancies”, at the 16th EHA Congress. The event will be held in London from 9th-12th June 2011.
At the same event Dr Reuben Mesa, principal investigator at Mayo Clinic, will be making a presentation entitled, “Phase 2 Study of SB1518, a Novel Oral JAK2 Inhibitor, in Patients with Primary, Post-Polycythemia Vera, and Post-Essential Thrombocythemia Myelofibrosis”.
Session:
Venue:
Room:
Session:
Venue:
Room:
|
11th June 2011, 5.30-6.45pm (Poster Presentation)
Excel, London, UK
North Halls (behind Registration Area)
Session – 12th June 2011, 8.30-8.45am (Oral Presentaion)
Venue – Excel, London, UK
Room – Platinum Suite 1
|
|
| June 2011 |
ASCO Annual Meeting |
|
Dr H.J. Deeg from the Fred Hutchinson Cancer Center, Seattle, Washington will present a poster entitled, “Phase II study of SB1518, an orally available novel JAK2 inhibitor, in patients with myelofibrosis”, at the ASCO Annual meeting. The event will be held in Chicago from 3rd-7th June 2011.
Dr Jan-Anders Karlsson (CEO) and Dr Joy Zhu (Senior Vice President, Global Clinical Development) from S*BIO will also be present at the event.
Session:
Venue:
Room:
|
3rd June 2011, 2-6 p.m, Poster Session
3rd June 2011, 5-6 p.m Poster Discussion Session
McCormick Place, Chicago, USA
Poster Discussion, Arie Crown Theater
Poster Session, E450b
|
|
| May 2011 |
BioEquity Europe 2011 |
|
Dr. Jan-Anders Karlsson, CEO of S*BIO, will be making a company presentation at the upcoming BioEquity Europe 2011 conference. This event will be held in Paris from 23 to 24 May 2011.
Session:
Venue:
Room:
|
24th May 2011, 11:00am
Marriott Rive Gauche, Paris, France
La Seine A
|
|
| April 2011 |
Future Leaders in the Biotech Industry 2011 – The 36th Clear Route Investment Conference |
|
Dr. Jan-Anders Karlsson, CEO of S*BIO, will be making a company presentation at the upcoming Future Leaders in the Biotech Industry 2011 conference organized by Biocentury and Thomson Reuters. This event will be held in New York on 15th April 2011.
Session:
Venue:
Room:
|
15th April 2011, 8:30am-8:55am
Millennium Broadway & Conference Center, New York
302/303
|
|
| April 2011 |
102nd AACR Annual Meeting 2011 |
|
Dr. Brian Dymock, Head of Chemistry and Dr Jeanette Wood, Head of Biology, will be presenting three posters at the upcoming AACR Annual Meeting. This event will be held in Orlando, Florida from 2nd- 6th April 2011.
Poster Title:
Session:
Abstract No.:
|
Design, synthesis and SAR studies leading to SB1518, a novel macrocyclic JAK2/FLT3 inhibitor in phase 2 clinical trials for myelofibrosis and lymphoma
PO.ET06.03. Kinase Inhibitors 1
Tuesday 5th April, 8am-12pm
3564
|
Poster Title:
Session:
Abstract No.:
|
SB1518, a novel JAK2/FLT3 inhibitor for the treatment of myeloid malignancies
PO.ET06.03. Kinase Inhibitors 1
Tuesday 5th April, 8am-12pm
3570
|
Poster Title:
Session:
Abstract No.:
|
Discovery of SB1317: A novel small molecule macrocycle with a unique kinase inhibitory spectrum in phase 1 clinical trials for hematological malignancies
PO.ET06.04. Kinase Inhibitors 2
Tuesday 5th April, 8am-12pm
3591
|
|
| February 2011 |
AACR Special Conference – Targeting PI3K/mTOR Signaling in Cancer |
|
Dr. Meredith Williams, Group Leader, Medicinal Chemistry and Dr Stefan Hart, Senior Scientist, will be presenting posters at the AACR Special Conference – Targeting PI3K/mTOR Signaling in Cancer. This event will be held in San Francisco from 24th- 27th February 2011.
Poster Title:
Session:
Venue:
|
SB2343, a novel tetra-substituted purine, inhibits mTOR and PI3K equipotently, and has favorable pharmacokinetic and pharmacodynamic properties and is orally efficacious in various cancer models
Poster Session A - 25 February 2011, 1:00pm-4:00pm
Hyatt Regency San Francisco
|
Poster Title:
Session:
Venue:
|
A novel series of tetra-substituted purines potently inhibit mTOR and PI3K, exhibit striking selectivity and demonstrate good pathway inhibition in vivo
Poster Session B - 26 February 2011, 7:30pm-10:00pm
Hyatt Regency San Francisco
|
Poster Title:
Session:
Venue:
|
Aminopyrazine substituted purines as potent and selective mTOR inhibitors
Poster Session B - 26 February 2011, 7:30pm-10:00pm
Hyatt Regency San Francisco
|
|
| February 2011 |
Keystone Symposia on Molecular and Cellular Biology – PI 3- Kinase Signaling Pathways |
|
Dr. Meredith Williams, Group Leader for Medicinal Chemistry, S*BIO, will be presenting a poster entitled “Lead Optimisation of a Series of Morpholine Triazines as mTOR/PI3K Inhibitors” at the Keystone Symposia on Molecular and Cellular Biology – PI 3- Kinase Signaling Pathways. This event will be held in Keystone, Colorado from 13th- 18th February 2011.
Session:
Venue:
Room:
|
16 February 2011, 7:30pm-10:00pm
Keystone Resort, Keystone, Colorado
Poster Session 3, Quandary Peak
|
|
| February 2011 |
BioComplexity Symposium & Workshop |
|
Dr. Kantharaj Ethirajulu, Head of Pre-Clinical Development, S*BIO, will be making an oral presentation entitled “Discovery and Development of SB939, a Superior Oral Histone Deacetylase Inhibitor” at the BioComplexity Symposium & Workshop 2011. This event will be held in Singapore from 14th- 15th February 2011.
Session:
Venue:
Room:
|
14 February 2011, 5:30pm-5:45pm
NUHS Tower Block, 1E Kent Ridge Road, Singapore
Auditorium
|
|
| February 2011 |
Pharma R&D World Asia Congress 2011 |
|
Dr. Jeanette Wood, Head of Biology, S*BIO, will be making an oral presentation entitled “Case Study- S*BIO: Discovery and Development of a Portfolio of Anti-Cancer Drugs with Potential in Autoimmune and Inflammatory Diseases” at the Pharma R&D World Asia Congress 2011. This event will be held in Singapore from 7- 8 February 2011.
Session:
Venue:
Room:
|
8 February 2011, 2:00-2:30pm
Concorde Hotel, Singapore
Concorde 2
|
|
| January 2011 |
Biomarkers in Diagnostics and Therapeutics |
|
Dr Stefan Hart, Senior, Scientist, will be making an oral presentation entitled “Translating biomarkers from preclinical to clinical applications: case studies from a Singapore Biotechnology Company” at the upcoming Biomarkers in Diagnostics and Therapeutics conference. This event will be held in Singapore from 24th-25th January 2011.
Session:
Venue:
Room:
|
25th January 2011, 10:55am
Orchard Hotel, Singapore
Lavender Room, Level 3
|
|
Events Archive
2010 Events
2009 Events
2008 Events
2007 Events
2006 Events
2005 Events
2004 Events
2003 Events
2002 Events
 Back to top
Copyright © 2002-2011 S*BIO Pte Ltd. All rights reserved.
|
|
